Printer Friendly

OSTEOTECH APPOINTS DR. DIXON AS INTERNATIONAL HEAD

 SHREWSBURY, N.J., Oct. 4 /PRNewswire/ -- Osteotech, Inc. (NASDAQ: OSTE) announced today that Wendy Dixon, Ph.D. has been appointed as executive vice president and general manager of international operations. Dr. Dixon will be responsible for Osteotech's international business which includes the company's subsidiary, HC Implants BV in Leiden, The Netherlands, as well as worldwide business development and licensing.
 Dr. Dixon has a diverse background with experience in the health care industry spanning 14 years. Most recently, she served as vice president, worldwide business development and, prior to that, as vice president, European marketing and sales of Centocor Inc. She has also had management positions of varying responsibilities at Smith Kline and French Pharmaceuticals (currently SmithKline Beecham), including business development, regulatory affairs and research. Dr. Dixon has been a B.S., M.S., in natural science and a Ph.D. in biochemistry from the University of Cambridge, Cambridge, England.
 Patrick McBrayer, president and chief executive officer of Osteotech, said that, "With her broad experience, Dr. Dixon will greatly enhance our efforts in expanding the company's international operations. Osteotech's acquisition of HC Implants BV significantly increased our product opportunities in biomaterials. She will be leading our efforts to grow the company internationally and will focus our efforts in the development and worldwide introduction of biomaterial products and in our corporate licensing activities. The company is very fortunate to have Dr. Dixon directing this significant business opportunity."
 Osteotech, Inc., headquartered in Shrewsbury, is a leading processor of human bone and bone connective tissue for transplantation and an innovator in the development and marketing of biologic, biomaterial and implant products for musculoskeletal surgery.
 -0- 10/4/93
 /CONTACT: Michael J. Jeffries of Osteotech, 908-542-2800/
 (OSTE)


CO: Osteotech, Inc. ST: New Jersey IN: MTC SU: PER

SH-MP -- NY028 -- 8184 10/04/93 09:03 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 4, 1993
Words:301
Previous Article:AMERICAN EXPLORATION COMPANY ANNOUNCES SOUTH TEXAS GAS DISCOVERY AND SEISMIC JOINT VENTURE
Next Article:NESTOR REPORTS OPERATING RESULTS FOR FISCAL YEAR ENDED JUNE 30, 1993
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters